Articles tagged with Affective Disorders
Dr. Amin's transformative insights reshape international understanding of depression genetics, identifying novel therapeutic targets and biomarkers for diagnosis and treatment. Her systemic disease model challenges traditional views of depression as a brain disorder.
Researchers have identified a rapid physiological marker that predicts which patients with major depression will respond to magnetic brain stimulation therapy. Patients whose heart rates slowed within 45 seconds of starting treatment showed significantly greater improvement in depressive symptoms six weeks later.
A study of 5,794 adults found that different types of depression are associated with varying levels of risk for cardiometabolic diseases. Those with atypical/energy-related symptoms were more likely to develop Type-2 diabetes, while those with melancholic symptoms were at higher risk for cardiovascular disease.
A renowned geneticist, Dr. Martin Alda, has made a groundbreaking discovery that bipolar disorder is composed of multiple genetically distinct disorders, transforming treatment approaches worldwide. His research also highlights the importance of combining basic research with clinical observations to advance psychiatric care.
Researchers identify abnormal sugar modifications linked to depressive behaviors, offering potential diagnostic and therapeutic targets. Chronic stress disrupts sugar chains in the prefrontal cortex, triggering depression.
Research in African populations aims to understand the link between depression and hypertension, two conditions affecting millions worldwide. The study will focus on identifying shared genetic mechanisms, which could lead to more effective treatment strategies for complex diseases.
The latest October issues of APA journals feature new research on adolescent suicidality and depression, premenstrual dysphoric disorder (PMDD), and safety issues related to ketamine and esketamine treatment. The American Journal of Psychotherapy also publishes a special issue on intensive short-term dynamic psychotherapy (ISTDP).
Dr. Gerhard Andersson's pioneering work in internet-delivered cognitive behavioral therapy has produced over 200 controlled trials and transformed mental healthcare accessibility across continents.
Professor Gregor Hasler's pioneering research reveals how psychedelics like LSD, psilocybin, and MDMA enhance neuroplasticity, allowing the brain to rewire itself and break free from depression, PTSD, and addiction. His discoveries have the potential to fundamentally alter international approaches to mental health treatment.
Professor Siegfried Kasper reveals biological bases of psychiatric disorders alongside psychosocial determinants, influencing treatment protocols globally. His pioneering research transformed approaches to treatment-resistant depression, improving millions of lives.
Researchers found that individuals with more severe depressive symptoms had difficulty learning to actively avoid aversive sounds, but their ability improved once they mastered the task. The study suggests that depressive symptoms may specifically interfere with learning to avoid unpleasant events rather than avoidance in general.
A computational framework has been created to understand how the brain's striatum region influences everyday decisions and impaired decision-making in individuals with psychiatric disorders. The study suggests that modulating striosomal activity could be a new approach to addressing psychiatric abnormalities.
Researchers found that older adults who challenge themselves to learn new things are less likely to experience loneliness or depression, even during the COVID-19 pandemic. Continued skill learning is associated with improved mental health outcomes, including greater resilience to external stressors and reduced depressive symptoms.
Folate and biopterin cofactors modulate disease mechanisms through shared enzymatic pathways and structural similarities. Key interactions include BH₄ salvage, enzyme substitution, and CNS folate-biopterin axis, highlighting the importance of their crosstalk in diseases such as depression, autism, and vascular disease.
Dr. David Rubinow's research reveals that susceptible women respond differently to normal hormonal fluctuations, leading to breakthrough treatment approaches and FDA-approved medication for postpartum depression. His work validates the experiences of millions of women whose hormone-related mood symptoms were previously misunderstood.
Researchers at the Institute for Basic Science have discovered that excessive GABA produced by astrocytes impairs fear extinction in PTSD. A new brain-permeable drug called KDS2010 has reversed PTSD-like symptoms in mice, providing a promising therapeutic approach.
The EmoWELL video game has been shown to improve emotional management in young university students by helping them identify, understand, and manage their emotions. Participants who played the game demonstrated reduced use of strategies that worsen emotional distress and improved self-acceptance.
A new study found that older adults with insomnia face triple the risk of developing depressive symptoms compared to sound sleepers. The study suggests that treatments targeted at inflammation-related depression may benefit these patients and improve their overall quality of life.
Researchers at the Salk Institute have identified a brain circuit that gives physical pain its emotional tone, revealing a potential target for treating chronic and affective pain conditions. The study found that a group of neurons in the thalamus can mediate the emotional side of pain in mice.
Dr. Danielle Beckman's research uses animal models to understand how viruses like COVID-19 trigger neurological damage and accelerate Alzheimer's disease. Her work has established critical connections between viral infections and neurodegenerative processes.
Researchers developed an individualized TMS targeting algorithm using large-scale brain imaging data to enhance treatment outcomes in depression. This approach, called MDD big data-guided individualized TMS targeting algorithm, produced targets more closely associated with symptom improvement.
A new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging found that individuals with remitted depression show increased habenula activity and reduced connectivity between the habenula and dopamine-producing regions, suggesting a heightened sensitivity to negative cues. This suggests that even after recove...
Research synthesizes evidence from dozens of studies on polygenic scores and their clinical implications, revealing consistent patterns that could contribute to personalized psychiatric care. Higher genetic risk for depression correlates with poorer treatment outcomes, including nonresponse to antidepressants and mood stabilizers.
A new study from the University of Pittsburgh suggests that excessive screen time and poor sleep quality may contribute to teen depression. The research found that teens who spent more time on screens and got less sleep had weaker brain connections, which can affect emotion regulation, memory, and attention.
Dr. Stephen Ross's groundbreaking studies using psilocybin therapy have demonstrated rapid, substantial, and sustained improvements in psychological symptoms for patients with advanced cancer, substance use disorders, and major depressive disorder. His research has the potential to challenge conventional psychiatric medication approaches.
Research found that approximately 50% of participants with late-life depression and bipolar disorder showed tau accumulation in their brains, compared to only about 15% of healthy controls. The study suggests that neurodegenerative diseases, including Alzheimer's, can initially manifest as psychiatric symptoms.
A recent study by Luiza Cesar Riani Costa and Diene Monique Carlos has provided insights into non-suicidal self-harm among adolescents. The booklet, featuring photographs and experiences of young people, offers a low-cost therapeutic and educational tool to address mental health concerns.
Professor Benedetti's research explores the intersection of genetics, environmental factors, and treatment response in mood disorders. His work has led to breakthroughs in chronotherapeutics and immuno-psychiatry, revealing crucial insights into immune-inflammatory mechanisms and gene variants influencing brain function.
A comprehensive review reveals that early ECT sessions show substantial improvement, but subsequent sessions may lead to diminishing returns and cognitive side effects. The researchers propose a response-guided sequential treatment strategy, categorizing patients into three groups based on their response patterns.
The June issues of The American Journal of Psychiatry and Psychiatric Services feature new research on treating depression and psychosis, as well as studies exploring postpartum mental health risks. These studies highlight the importance of predicting postpartum depression and developing effective treatment models.
A WVU microbiology student has discovered a new species of fungus, Periglandula clandestina, that produces effects similar to the semisynthetic drug LSD. The fungus is highly efficient at making ergot alkaloids, which can be used therapeutically to treat conditions like depression and addiction.
Attachment theory is used to understand human-AI relationships, revealing anxiety and avoidance tendencies. The study suggests AI chatbots can be tailored to meet users' emotional needs, promoting psychological well-being.
A large observational study suggests that US general military service may actually lower, rather than heighten, the risk of depression. The study found a 22-23% lower risk of depression associated with military service, after adjusting for influential factors such as age, sex, and income.
A systematic review of studies found that policies improving paid parental leave, employment access, housing stability, and income support are associated with lower rates of depression. Conversely, cuts to social welfare and financial insecurity increase depression risk, particularly among single parents and low-income households.
Researchers found that specific combinations of personality traits can predict bipolar disorder outcomes, with certain styles raising and others lowering the risk of depression. The study used data from over 2,500 people with bipolar disorder and suggests a personalized approach to treatment planning.
Researchers identify enlarged salience network as first reliable biomarker for depression risk, predicting symptoms before they appear. The network's expansion could enable early identification and intervention, leading to improved quality of life and treatment outcomes.
Children from disadvantaged neighborhoods show blunted response to reward and loss, especially those with family history of depression. Growing up in chronically stressful environments may dampen reaction to good or bad events, increasing depression risk.
Researchers have found that people with cannabis use disorder have elevated dopamine levels in a brain region associated with psychosis. This could explain why frequent cannabis use increases the risk of hallucinations and delusions. The study's findings may help doctors educate patients about the potential risks of frequent cannabis u...
The study found significant improvements in symptoms for participants with major depressive disorder, generalized anxiety disorder, and eating disorders. Participants reported trusting and communicating with Therabot comparable to working with a therapist.
A new study by UNLV researchers finds that diabetes weakens the anterior cingulate cortex, suppressing reward perception and memory signals, leading to mild cognitive impairment. The connection between high blood sugar levels and Alzheimer's disease may be linked to altered hippocampal theta synchrony.
A rat study found that type 2 diabetes can suppress the activity of the anterior cingulate cortex, a region critical for cognition and emotions. This weakening affects reward signals and leads to altered behavior, highlighting a potential link between T2D and psychiatric disorders.
Research reveals nearly 10% of individuals with disabilities misused prescription drugs in the past year, compared to 4.4% without disabilities. Young adults and those with cognitive disabilities are particularly vulnerable to prescription drug misuse.
Dr. Nicholas Fabiano's research reveals exercise reduces suicide attempts but shows no connection to thoughts of suicide or deaths by suicide. His work proposes a paradigm shift in mental health treatment, suggesting exercise as a first-line treatment for depression.
A new study published in Brain Medicine reveals that over 26.7% of schizophrenia patients experience distinct manic symptoms, which can be predicted by the severity of positive symptoms such as hallucinations and delusions.
The latest issues of APA journals bring together research on addictions, including substances and behaviors. The February issue of the American Journal of Psychiatry highlights research on addictions, while Psychiatric Services features articles on various mental health topics.
Researchers found a strong link between depression and menstrual pain in a new study published in Briefings in Bioinformatics. Depression may be a cause of dysmenorrhea, rather than a consequence, according to the findings.
A recent study by UCL researchers reveals that people with poorer mental health are more prone to browsing negative content online, which further exacerbates their symptoms. The study found that adding 'content labels' to webpages can help users make healthier and more informed decisions about the content they consume.
KTU researchers have developed an AI model that achieves 97.53% accuracy in diagnosing depression using a combination of speech and brain neural activity data. The multimodal approach provides a more accurate and objective analysis of a person's emotional state, opening the door to new depression diagnosis methods.
A new study from the University of Georgia analyzed Reddit posts in the self-harm subreddit and found that users often view self-injury as an addictive behavior. The researchers caution that online communities cannot replace face-to-face interactions and professional help for mental health support.
A novel sensory CBT treatment strategy has demonstrated its potential in a pre-clinical study, improving participants' ability to discard items and reducing anxiety and distress. The study found that imagery rescripting was more effective than other techniques in promoting discarding behavior and reducing negative emotions.
This study suggests that gamified digital mental health interventions can be an effective treatment option for youth with ADHD or depressive disorders. The findings provide new information for pediatricians and healthcare professionals seeking innovative solutions for pediatric mental health care.
A novel LED device with alternating orange and blue wavelengths has been shown to effectively reset circadian clocks in humans. The study found that the light outpaced other devices in advancing melatonin levels, offering a new approach to counteract seasonal affective disorder.
Researchers have developed an integrated optical sensor capable of detecting dopamine directly from unprocessed blood samples. This breakthrough enables low-cost and efficient screening tools for various neurological conditions and cancers.
Researchers have developed a cost-effective and easily reproducible point-of-care testing device that can accurately measure cortisol levels in the blood. The device uses iridium oxide nanoparticles to improve stability, sensitivity, and selectivity, allowing for commercial use.
A disproportionality analysis of World Health Organization data revealed a signal of semaglutide-associated suicidal ideation, particularly among patients with co-reported antidepressant use. This finding warrants urgent clarification and highlights the need for further research on the safety profile of semaglutide.
A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). VR-Enhanced Behavioral Activation (XR-BA) was found to be effective in easing symptoms of depression, comparable to traditional behavioral activation.
Researchers at Children's Hospital of Philadelphia found that teens and young adults with mood disorders are 30% less likely to obtain their driver’s license compared to peers without such disorders. These youths also experienced a slightly elevated risk of crashing, particularly when newly licensed.
A nationwide Swedish study reveals a bidirectional link between premenstrual disorders (PMS/PMDD) and perinatal depression. Women with PMS/PMDD are five times more likely to experience perinatal depression, while those with perinatal depression are twice as likely to develop PMS/PMDD.
A new study by the University of Southampton found that a commonly used questionnaire for monitoring depression treatment in primary care does not provide immediate benefits. However, patients who tracked their scores reported improved overall wellbeing and quality of life after six months.
A new task force formed under C-Path's Rare Disease Cures Accelerator-Data and Analytics Platform aims to advance therapeutic development for Progressive Supranuclear Palsy (PSP). The collaboration leverages collective expertise to foster innovation, identify critical gaps in research, and expedite treatment advancements.